ANNUAL REPORT 2024
The European Medicines Agency's contribution to science, medicines and health in 2024
Download PDF version
Chapter 1
Key achievements in 2024
The first chapter focuses on EMA's strategic priorities and contributions to public and animal health in Europe. Click on the links below to learn more about the most important highlights in the evaluation and monitoring of human and veterinary medicines and major achievements in 2024.
Key activities and events in 2024
Explore timeline
EMA by numbers
Key figures on EMA's recommendationsfor the authorisation of new medicines in 2024:
0
positive opinionsfor human medicines
0
positive opinionsfor veterinary medicines
0
human medicineswith a new active substance
0
veterinary medicineswith a new active substance
0
negative opinionsfor human medicines
0
negative opinionsfor veterinary medicines
Chapter 2
Key figures in 2024
The second chapter presents a selection of key figures and trends illustrating EMA's activities in the regulation of medicines in the EU. Click on the links below for core statistics.
